VTRS

#623
Viatris Inc. - Common Stock
16.1 9 USD
+0.50%
부문: 헬스케어
베이스: USD
수익 통화: USD
일일 변동 비율
16.07
16.19
년간 변동
0.16
17.53
일일 변동
+0.50%
월간 변동
+7.43%
6달 변화
+52.23%
년간 변동율
+56.43%
이전 종가
16.1 1
Open
16.0 8
저가
16.0 7
High
16.1 9
양
1 725
전체 차트 열기 Full chart

Financials

개요 성명 통계 배당금
4분기 연간
  • Market Capitalization 18.85 B
  • Employee 30 K
  • Founded 2020
  • CEO Scott A. Smith
  • Website www.viatris.com
  • Headquarter Delaware, United States
  • FIGI BBG00Y4RQNH4
  • Industry 전문의약품 및 제네릭 의약품 제조업체
총매출
순이익
주당 순이익(기본 EPS)
총부채
잉여 현금 흐름
현금 및 현금성 자산
주가수익비율
-4.15
주가매출액비율
—
주당 배당금
0.48
배당수익률 %
3.86

Viatris Inc. - Common Stock

Viatris Inc. is an American global pharmaceutical and healthcare corporation headquartered in Canonsburg, Pennsylvania. The corporation was formed through the merger of Mylan and Upjohn, a legacy division of Pfizer, on November 16, 2020. The name of the corporation comes from the Latin words via, meaning path, and tris, which means three, referring to the path to three main objectives the corporation set: expanding access to medicines, meeting patient needs through innovation, and earning the trust of the healthcare community. Viatris ranked 254th on the 2021 Fortune 500 rankings of the largest United States corporations based on its 2020 total revenue.

뉴스